Table 2

Group differences in demographic information, PCL-5 scores and sleep quality between the RD patient group and the control group

Patients with RDControlχ2/tP value
Mean/NSD/%Mean/NSD/%
Total486100.00486100.00
Age
18–3422345.9021343.803.4180.181
35–6020341.8022746.70
>606012.30469.50
Gender
Male30161.9030262.100.0040.947
Female18538.1018437.90
PCL-5 Scores
Total scores18.4011.4711.0710.04−10.601<0.001
Criterion B4.863.403.223.34−7.577<0.001
Criterion C2.211.970.891.43−11.978<0.001
Criterion D6.204.593.583.93−7.617<0.001
Criterion E5.123.663.583.48−10.601<0.001
Sleep quality
Subjective sleep quality1.190.770.780.76−8.424<0.001
Difficulty falling asleep1.071.090.510.88−8.782<0.001
Frequent nocturnal or early morning awakening1.411.160.821.06−8.269<0.001
Sleep duration0.950.850.770.85−3.2170.001
  • PCL-5, PTSD checklist for DSM-5; RD, rheumatic diseases.